About hologic inc. - HOLX
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
HOLX At a Glance
Hologic, Inc.
250 Campus Drive
Marlborough, Massachusetts 01752
| Phone | 1-508-263-2900 | Revenue | 4.10B | |
| Industry | Medical Specialties | Net Income | 565.70M | |
| Sector | Health Technology | 2025 Sales Growth | 1.742% | |
| Fiscal Year-end | 09 / 2026 | Employees | 7,070 | |
| View SEC Filings |
HOLX Valuation
| P/E Current | 31.336 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 27.038 |
| Price to Sales Ratio | 3.73 |
| Price to Book Ratio | 2.963 |
| Price to Cash Flow Ratio | 14.47 |
| Enterprise Value to EBITDA | 12.391 |
| Enterprise Value to Sales | 3.834 |
| Total Debt to Enterprise Value | 0.167 |
HOLX Efficiency
| Revenue/Employee | 579,985.856 |
| Income Per Employee | 80,014.144 |
| Receivables Turnover | 6.825 |
| Total Asset Turnover | 0.451 |
HOLX Liquidity
| Current Ratio | 3.754 |
| Quick Ratio | 3.058 |
| Cash Ratio | 2.254 |
HOLX Profitability
| Gross Margin | 55.771 |
| Operating Margin | 23.626 |
| Pretax Margin | 16.613 |
| Net Margin | 13.796 |
| Return on Assets | 6.226 |
| Return on Equity | 11.116 |
| Return on Total Capital | 7.371 |
| Return on Invested Capital | 7.364 |
HOLX Capital Structure
| Total Debt to Total Equity | 52.037 |
| Total Debt to Total Capital | 34.227 |
| Total Debt to Total Assets | 29.138 |
| Long-Term Debt to Equity | 51.376 |
| Long-Term Debt to Total Capital | 33.792 |